Sign in

    PETMED EXPRESS (PETS)

    Q4 2025 Earnings Summary

    Reported on Jan 1, 1970
    Pre-Earnings Price$3.55Open (Jun 16, 2025)
    Post-Earnings Price$3.49Last close (Jun 17, 2025)
    Price Change
    $-0.06(-1.69%)
    MetricYoY ChangeReason

    General & Administrative Expenses

    -$6M to -$8M

    The restatement process reduced previously overstated expenses by $6M–$8M for fiscal 2023, which in turn increased net income in the current period compared to prior periods

    Sales Tax Liabilities

    Adjustment: $16M to $23M increase

    A correction in the accounting approach for sales tax liabilities—shifting from a “probable and estimable” method to recognizing the maximum legal potential liability—resulted in an upward adjustment of $16M–$23M compared to earlier period estimates

    Net Income

    Increase (implied)

    Due to the reduction in general and administrative expenses from the restatement, net income increased in the current period relative to previous periods, demonstrating the effect of correcting historical accounting errors

    Revenue and Cash

    No change

    Despite the restatement adjustments, revenue, cost of goods sold, and cash balances (with cash and equivalents reported at $49.4M) remained unaffected, indicating that the corrections were technical adjustments rather than operational shifts

    Research analysts covering PETMED EXPRESS.